Cytospire Therapeutics

Cytospire

This biotechnology company develops multispecific immune cell engager antibodies to treat patients with solid and liquid tumours.

Avidicure

This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.

Clasp Therapeutics

This company develops T cell engagers that target oncogenic driver mutations to treat patients with solid tumours.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

TILT Biotherapeutics

This company develops oncolytic viral immunotherapies to treat patients with solid tumours by enhancing immune system responses against cancer cells.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.